Curative Efficacy of Mitomycin C Combined with TobraDex Ophthalmic Ointment in KTP Laser-Assisted Dacryocystorhinostomy for Lacrimal Duct Obstruction

Lei MAO,Chun-lan LIU,Qiong ZHOU
DOI: https://doi.org/10.13764/j.cnki.lcsy.2015.03.029
2015-01-01
Abstract:ABSTRACT:Objective To investigate the clinical efficacy of mitomycin C(MMC)combined To-braDex ophthalmic ointment(TDO)in KTP laser-assisted dacryocystoplasty(LDCL)for lacrimal duct obstruction.Methods A total of 218 patients with lacrimal duct obstruction(218 eyes)were divided into three groups.The group A(n= 100)was treated with MMC,TDO and LDCL.The group B(n=88)was treated with MMC and LDCL.The group C(n=30)was treated with LDCL alone.Clinical efficacy was compared among the three groups.Results All patients were followed up for more than 6 months.In group A,82 patients were cured,7 patients had improvement,and 11 patients underwent ineffective treatment.In group B,60 patients were cured,9 patients had im-provement,and 19 patients underwent ineffective treatment.In group C,14 patients were cured,7 patients had improvement,and 9 patients underwent ineffective treatment.The total effective rate in group A(89.0%,89/100)was significantly higher than that in group B(78.4%,69/88)and group C(70.0%,21/30)(P <0.05).Conclusion The MMC combined with TDO can improve the long-term effect of LDCL in patients with lacrimal duct obstruction.
What problem does this paper attempt to address?